Maria Del Carmen Candia Plata, Juan Manuel Martínez Soto, Jeanette Guadalupe Arredondo Damián, Astrid Nallely Ramírez Romero Ramírez Romero, Lucía Guadalupe Villegas Coronado, Jesús Adriana Soto Guzmán, Luis Fernando López Soto, Ana Lourdes Mata Pineda, Gerardo Álvarez Hernández, José Manuel Galván Moroyoqui
{"title":"Ferroptosis-associated microRNAs: Systematic review.","authors":"Maria Del Carmen Candia Plata, Juan Manuel Martínez Soto, Jeanette Guadalupe Arredondo Damián, Astrid Nallely Ramírez Romero Ramírez Romero, Lucía Guadalupe Villegas Coronado, Jesús Adriana Soto Guzmán, Luis Fernando López Soto, Ana Lourdes Mata Pineda, Gerardo Álvarez Hernández, José Manuel Galván Moroyoqui","doi":"10.14715/cmb/2025.71.4.1","DOIUrl":null,"url":null,"abstract":"<p><p>Ferroptosis, an iron-dependent form of regulated cell death characterized by lipid peroxidation, has emerged as a critical process in various diseases. MicroRNAs (miRNAs), small non-coding RNAs that regulate gene expression, are increasingly recognized as key modulators of ferroptosis pathways. This systematic review aims to provide a comprehensive overview of the current knowledge regarding miRNAs implicated in ferroptosis across a spectrum of diseases. We conducted a systematic search of EMBL-EBI, PubMed, Scopus, and Web of Science databases to identify relevant studies published up to October 31, 2022. Our search strategy identified 127 articles encompassing 107 distinct miRNAs that influence ferroptosis. This review synthesizes the findings of these studies, highlighting the specific miRNAs that act as either inhibitors or inducers of ferroptosis in different disease contexts, including various cancers (e.g., lung, breast, colorectal) and degenerative conditions (e.g., acute renal failure, diabetic retinopathy). We discuss the molecular mechanisms by which these miRNAs regulate ferroptosis, often by targeting key genes involved in iron metabolism, lipid peroxidation, and antioxidant defense. Furthermore, we explore the potential of these miRNAs to serve as diagnostic biomarkers and therapeutic targets in ferroptosis-related disorders, offering insights into novel strategies for disease management.</p>","PeriodicalId":9802,"journal":{"name":"Cellular and molecular biology","volume":"71 4","pages":"1-14"},"PeriodicalIF":1.5000,"publicationDate":"2025-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cellular and molecular biology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.14715/cmb/2025.71.4.1","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Ferroptosis, an iron-dependent form of regulated cell death characterized by lipid peroxidation, has emerged as a critical process in various diseases. MicroRNAs (miRNAs), small non-coding RNAs that regulate gene expression, are increasingly recognized as key modulators of ferroptosis pathways. This systematic review aims to provide a comprehensive overview of the current knowledge regarding miRNAs implicated in ferroptosis across a spectrum of diseases. We conducted a systematic search of EMBL-EBI, PubMed, Scopus, and Web of Science databases to identify relevant studies published up to October 31, 2022. Our search strategy identified 127 articles encompassing 107 distinct miRNAs that influence ferroptosis. This review synthesizes the findings of these studies, highlighting the specific miRNAs that act as either inhibitors or inducers of ferroptosis in different disease contexts, including various cancers (e.g., lung, breast, colorectal) and degenerative conditions (e.g., acute renal failure, diabetic retinopathy). We discuss the molecular mechanisms by which these miRNAs regulate ferroptosis, often by targeting key genes involved in iron metabolism, lipid peroxidation, and antioxidant defense. Furthermore, we explore the potential of these miRNAs to serve as diagnostic biomarkers and therapeutic targets in ferroptosis-related disorders, offering insights into novel strategies for disease management.
铁死亡是一种以脂质过氧化为特征的铁依赖性细胞死亡形式,已成为多种疾病的关键过程。MicroRNAs (miRNAs)是调节基因表达的小非编码rna,越来越被认为是铁死亡途径的关键调节剂。这篇系统综述的目的是提供一个全面的概述,目前的知识关于mirna涉及铁下垂在一系列疾病。我们对EMBL-EBI、PubMed、Scopus和Web of Science数据库进行了系统检索,以确定截至2022年10月31日发表的相关研究。我们的搜索策略确定了127篇文章,其中包括107种不同的影响铁下垂的mirna。这篇综述综合了这些研究的结果,强调了在不同疾病背景下作为铁下垂抑制剂或诱导剂的特定mirna,包括各种癌症(如肺癌、乳腺癌、结肠直肠癌)和退行性疾病(如急性肾衰竭、糖尿病视网膜病变)。我们讨论了这些mirna调节铁死亡的分子机制,通常通过靶向涉及铁代谢、脂质过氧化和抗氧化防御的关键基因。此外,我们还探索了这些mirna作为嗜铁相关疾病的诊断生物标志物和治疗靶点的潜力,为疾病管理的新策略提供见解。
期刊介绍:
Cellular and Molecular Biology publishes original articles, reviews, short communications, methods, meta-analysis notes, letters to editor and comments in the interdisciplinary science of Cellular and Molecular Biology linking and integrating molecular biology, biophysics, biochemistry, enzymology, physiology and biotechnology in a dynamic cell and tissue biology environment, applied to human, animals, plants tissues as well to microbial and viral cells. The journal Cellular and Molecular Biology is therefore open to intense interdisciplinary exchanges in medical, dental, veterinary, pharmacological, botanical and biological researches for the demonstration of these multiple links.